Health & Wellness Alliance: medical and biotech briefing

Summary

This briefing sorts the member companies of the Health & Wellness Alliance into the four supply-chain tiers the alliance publishes. It sets out the alliance's direction, shows what representative companies make in each tier, and lists questions to ask before formal review. It is written for overseas buyers looking for medical consumables, testing platforms or health ingredients, and for investors assessing Taiwanese medical technology and biotech companies.

As of 4 November 2026, the TINAI company directory lists 17 member companies, none of them listed in another alliance. Twelve carry a stock code: ten on the Taipei Exchange and two on the Taiwan Stock Exchange. The other five carry none. One entry, a production site in Vietnam, is not assigned to any tier, while one company appears in two tiers, so the tier counts below still add up to 17.

Direction of the alliance

The alliance aims to bring together biotech and pharmaceutical, medical equipment and health service capability, from research and contract development and manufacturing to clinical application and market channels, to build an internationally competitive health industry. It sets out three strategies: use a contract development and manufacturing organisation (CDMO) model to combine research and manufacturing; link clinical settings to speed up validation; and integrate channels to widen market reach.

Each strategy needs named members behind it, and public data has clear gaps here. No company description in the directory mentions CDMO services, so the briefing cannot say which members carry out contract development and manufacturing. The alliance page's solutions section shows no data, and there are no public partners or cases for clinical-setting links.

The alliance page's case-study section also shows no data, and its introductory text describes the automotive value chain, not health, so the briefing does not cite it. Its three headline result figures carry no labels either. Company counts come from the TINAI directory, counted entry by entry.

Medical technology and smart care

The medical technology tier lists six companies, mostly consumables and devices. The medical-glove group PM Gloves (英屬維京群島商禾寶醫療器材股份有限公司) makes medical gloves in nitrile, PVC and thermoplastic elastomer, as well as cleanroom gloves. LAGIS Enterprise (常廣股份有限公司) makes minimally invasive surgical instruments and consumables under its own LAGIS brand and exports to more than 50 countries. 沃醫學股份有限公司 works in aesthetic medicine and medical devices, including body contouring and plastic surgery.

Three companies cover testing and information. BiOptic (光鼎生物科技股份有限公司) develops capillary electrophoresis technology and offers a genetic testing platform and automated nucleic acid extraction. Creative Life Science (啟新生物科技股份有限公司) supplies biomedical consumables and technical services for biopharmaceutical, food-safety and infectious-disease testing. Onyx Healthcare (醫揚科技股份有限公司) makes medical AI platforms and medical-grade computers, including medical tablets, displays and smart operating-room systems.

The smart care tier has one entry, 蕭中正醫院, which provides specialist and community medical services. The alliance describes this tier as wearable devices, remote-care platforms and long-term care data systems, but no company in the directory describes such products. Readers interested in remote care or long-term care technology should say so in the request form so the alliance can confirm whether members are still to be listed.

Biotech and pharmaceuticals

The biotech and pharmaceuticals tier lists three companies. TCM Biotech International (泰宗生物科技股份有限公司) is a new-drug company whose business covers a medical testing platform, pharmaceuticals and medical devices. Syngen Biotech (生展生物科技股份有限公司) develops and makes fermentation-based active ingredients and nutritional supplements, and has moved into preventive medicine and animal health. Daiken Biomedical (大研生醫國際股份有限公司) runs a nutritional-supplement brand with fish oil, lutein and probiotics, and is also listed under healthy living.

The alliance describes this tier as covering drug development, cell therapy, nutritional supplements and clinical trials. The directory's descriptions cover drugs, active ingredients and supplements, but none mentions cell therapy or clinical-trial services. The briefing reports only what the public descriptions show and adds no inference.

Healthy living and related industries

The healthy living tier lists seven companies and is the loosest in scope. The alliance says it covers health foods, medical devices, health management and functional drinks. Sunway Biotech (晨暉生物科技股份有限公司) develops biochemical technology, health ingredients and pet health products. 品元實業股份有限公司 imports food ingredients and makes pre-mixed powders, including baking and beverage powders. Daiken Biomedical also appears in this tier.

The tier also holds consumer brands and electronics. Sun Own Industrial (歐都納股份有限公司) is an outdoor brand selling functional clothing, hiking boots, backpacks, tents and water-sports gear. Mikobeaute International (霈方國際股份有限公司) runs a skincare brand with department-store counters and shops. 佐登妮絲國際股份有限公司 offers beauty spa and aesthetic medicine services, and makes cosmetics under contract. Eiso Enterprise (邑昇實業股份有限公司) makes circuit boards used in power, industrial control, networking, vehicle and medical products.

The companies in this tier differ widely, so a buyer should first decide whether the need is health ingredients, food ingredients, consumer brands or medical electronic components, and then read the company pages. One further directory entry, a production site in Vietnam, is not assigned to any tier, and the briefing does not use it as a representative example of the alliance.

Using the briefing, and questions before formal review

Start from the product. Medical technology covers gloves, surgical instruments and testing equipment; biotech and pharmaceuticals covers drugs, active ingredients and supplements; healthy living covers health ingredients, food ingredients and related consumer goods. Then open the company page in the directory and ask for product specifications and quality-management documents. The briefing reproduces public descriptions only and has not checked these documents.

Medical device licences, drug and health-food registrations, clinical partnerships and export conditions are not in public data and must be asked of each company. Rules differ by market. A financial investor might first ask which capabilities need controlled due diligence to confirm. A strategic investor might ask which product, value-chain position or partnership record still needs verification, and whether the company can offer contract development and manufacturing.

Buyers with a specific need can submit the cooperation-request form, stating the item and its use. The platform makes a referral only after both sides agree, and the parties then negotiate directly. A listing is an information summary and does not mean capability has been verified. Nothing here is medical advice.